Pharmacy Times interviewed Dapo Amosu, MS, PharmD, DPLA, on his ideas on find out how to advance treatment use processes in inpatient and ambulatory settings, the position of the pharmacist in inpatient and ambulatory settings, and the position know-how and AI might play sooner or later as they arrive to the fore in pharmacy processing of information. Amosu stepped into his new position because the senior director of pharmacy at Fox Chase Cancer Center (Fox Chase) in Philadelphia on August 7, 2023.
About the Expert
Dapo Amosu, MS, PharmD, DPLA, started his tenure on August 7 because the senior director of pharmacy at Fox Chase Cancer Center (Fox Chase) in Philadelphia. As nicely as overseeing the treatment use course of for each the inpatient and ambulatory care environments, Amosu will serve on key committees inside Fox Chase, such because the Research Review Committee and Performance Improvement Committee, and also will characterize Fox Chase within the broader oncology enviornment, together with on the rules committees of the National Comprehensive Cancer Network and the Pharmacy Directors Committee of the Alliance of Dedicated Cancer Centers. He will work intently and collaboratively with clinicians, senior management, and colleagues from varied departments concerning pharmacy packages and associated affected person care companies, together with the supply of pharmaceutical companies, the state of related know-how and tools, and affected person security issues.
Amosu has over 25 years of pharmacy expertise, with experience in hematology/oncology pharmacy, medical analysis, and pharmacy administration. He just lately managed oncology medical pharmacy companies for Beebe Healthcare in Southern Delaware, and previous to this he spent practically 10 years at Medstar-Georgetown University Hospital – Vince Lombardi Comprehensive Cancer Center in Washington, DC, in roles in oncology and analysis pharmacy companies. During the latter position, he additionally served as an adjunct medical professor at Howard University School of Pharmacy. Amosu acquired his BS in Pharmacy and PharmD levels from Howard University, and he holds an Health-System Pharmacy Administration from The Ohio State University.
Pharmacy Times: As you step into this position as senior director of pharmacy, what challenges do you see forward as being pivotal to advance treatment use processes in inpatient and ambulatory settings at Fox Chase amenities?
Amosu: Medication use course of is the foundational system that gives the requisite framework for protected use of treatment throughout the well being system. Cancer care is normally delivered in a posh surroundings and protected use of treatment stays one of many overriding components within the supply of care to our sufferers. All efforts have to be made to make sure that the protected treatment use is maintained. Putting vital safeguards in place to make sure that the continued provide chain disruption doesn’t negatively influence our treatment use course of is a vital problem that we are going to proceed to handle.
Clinical pharmacy specialists in all affected person care settings play important roles in guaranteeing that our sufferers proceed to obtain the best therapies; their participation in multidisciplinary remedy coordination, engagement in transition of care and continuum of care processes, and stopping inappropriate use of treatment that may doubtlessly result in affected person hurt, suboptimal well being outcomes, and enhance value of care is crucial to development of treatment use course of.
Inclusion of a pharmacy specialist in a clinically-oriented, multidisciplinary team-based follow mannequin yields good remedy outcomes and prevents suboptimal well being outcomes. Fox Chase is dedicated to guaranteeing that these companies are delivered by our pharmacy staff as we develop methods to sort out pharmacist and pharmacy technician recruitment and retention challenges. We will proceed to make the most of out there know-how together with automation, to optimize supply of pharmaceutical companies with the aim of advancing each side of the treatment use processes.
Pharmacy Times: How has the position of the pharmacist in inpatient and ambulatory settings modified lately, and what extra would you prefer to see executed to advance that position?
Amosu: Pharmacists’ position in affected person care continues to evolve in each inpatient and ambulatory settings. Some of the rising pharmacist’ roles within the inpatient setting embody pharmacy participation in transition of care (TOC), which focuses on the continuity of affected person care from the hospital to residence upon discharge, and vice-versa.
TOC pharmacists reconcile affected person treatment file to stop treatment errors, guarantee continuity of remedy, and scale back readmission charges. Studies have proven that TOC pharmacy program reduces 30-day hospital’s readmission charge by 14.5%.
Also, treatment security pharmacists are important in all well being care settings. They establish deficiencies within the treatment use course of by analyzing treatment security reviews and establish alternatives to enhance the protection of treatment use together with adjustments to prescribing practices. Pharmacist’s position in pharmacy-based acute oncology care optimization program will proceed to develop; this contains number of greatest remedy plans and applicable supportive care agent(s), affected person training, and monitoring plus administration of treatment-related hostile occasions (AEs).
Pharmacy Times: What is the position of the pharmacist in affected person care at present in inpatient and ambulatory environments on the Temple University Hospital (TUH)?
Amosu: Our pharmacists are actively concerned in all elements of the treatment use course of, making medical interventions and remedy suggestions for improved affected person outcomes, and in addition taking part within the improvement and implementation of follow insurance policies throughout the TUH System. Their roles are centered on supply of protected, efficient, patient-centered pharmaceutical companies. Their scope of follow has prolonged into care coordination inside their respective multidisciplinary staff and continuum of care past hospital keep.
Our pharmacists are actively concerned in all elements of the treatment use course of, making medical interventions and remedy suggestions for improved affected person outcomes, and in addition taking part within the improvement and implementation of follow insurance policies throughout the TUH System. Image Credit: Adobe Stock – natali_mis
Pharmacy Times: How is Fox Chase being impacted by provide chain challenges at present, and the way is it responding to those challenges?
Amosu: Shortages of prescription drugs together with intravenous options proceed to beset the well being care programs. Despite the challenges introduced by this provide chain disruption, FCCC continues to satisfy the pharmaceutical wants of our sufferers. We are in a position to accomplish this by implementation of greatest practices suggestions that embody therapeutic interchange, dose adjustment, conversion from IV to oral formulation, when applicable, and alter in route of administration, intermittent infusion to IV push. In restricted circumstances, now we have labored with our multidisciplinary staff to revise remedy plans so we are able to make different remedy choices out there to our sufferers. All these have been carried out with out disruptions in care supply or compromise in high quality of therapies administered.
Pharmacy Times: How has your expertise in a privately owned outpatient most cancers remedy middle helped to tell your perspective round your work at Fox Chase Cancer Center?
Amosu: The follow challenges are related throughout these 2 settings together with the financial burden (monetary toxicity) that most cancers sufferers expertise from the prices of remedy.
Treatment and administration of most cancers proceed to shift into the hospital ambulatory and neighborhood house. Many of the chemotherapy regimens that have been administered within the inpatient setting prior to now are actually safely administered within the outpatient setting, and the significance of guaranteeing that these regimens are administered safely on this fast-paced surroundings can’t be overemphasized. The variety of sufferers receiving chemotherapy companies by the Fox Chase – TUH community continues to extend as we endeavor to satisfy the wants of our sufferers and develop our attain to rapid communities. Our aim is to make sure that we ship efficient pharmaceutical care safely and effectively.
Pharmacy Times: What is your view on the long run we’re heading towards because the position of know-how and AI come to the fore in pharmacy processing of information?
Amosu: Technology continues to positively influence all steps within the treatment use course of. AI is being utilized in many areas of the well being care system to stop treatment errors and as a predictive analytic software to handle remedy final result, drug stock, and medicine adherence; it might additionally assist to foretell the severity of AEs based mostly on out there affected person’s genetic info. AI shall be very helpful within the number of probably the most “cost-effective regimen” particularly for prime value remedy choices. Some of those attributes will immediately or not directly result in discount in hospital readmissions.
[adinserter block=”4″]
Source link
